Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
In order to provide a new option for clinical anti-angiogenesis therapy in hepatoma, a randomized controlled study is planed to confirm the effect of Rg3 in combination with TACE on angiogenesis and tumor treatment in advanced hepatocellular carcinoma patients with high expression of Notch1.
Epistemonikos ID: 31c349edfb76e185acc4d92632cfc18556bd584b
First added on: May 12, 2024